H.R. 6320 · 119th Congress · Health
Improving Medicaid Precision and Cancer Test Act of 2025
- IntroducedNov 28, 2025 Done
- CommitteeReferred to Energy and Commerce Current stage
- House floorNot yet Not reached yet
- Senate floorNot yet Not reached yet
- Chambers agreeNot yet Not reached yet
- PresidentNot yet Not reached yet
Full text
No CRS summary yet · 151 wordsH.R. 6320 · Introduced in House · Nov 28, 2025
This Act may be cited as the Improving Medicaid Precision and Cancer Test Act of 2025 .
(a) In general. Title XIX of the Social Security Act ( 42 U.S.C. 1396 et seq. ) is amended— (1) in section 1902(a)(10)(A), in the matter preceding clause (i), by striking and (30) and inserting (30), and (32) ; (2) in section 1905— (A) in subsection (a)— (i) in paragraph (31), by striking ; and and inserting a semicolon; (ii) by redesignating paragraph (32) as paragraph (33); and (iii) by inserting the following paragraph after paragraph (31): (32) lung cancer biomarker testing; and ; and (3) in section 1937(b)(5), by inserting before the period at the end the following: , and beginning January 1, 2027, coverage of lung cancer biomarker testing .
(b) Effective date. The amendments made by this section shall apply beginning January 1, 2027.
Shown here because the text is under 500 words. Open on Congress.gov
Who lobbies on it
No lobbying filing on file names H.R. 6320.
Organizations that named H.R. 6320 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. Source: Senate lobbying disclosures (LD-2) from lda.gov; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.
Actions
2 actions · newest first- Nov 28, 2025Referred to the House Committee on Energy and Commerce.
- Nov 28, 2025Introduced in House